ROCKVILLE, MD., Sept 19 - William Haseltine is a party pooper.  

While others have celebrated the near completion of a working draft of the human genome, Haseltine, chairman and CEO of Human Genome Sciences (Nasdaq: HGSI), dismisses the accomplishment as more conceptual than scientific. 

“The human genome, from my point of view,” said Haseltine, “is not useful for medicine.”

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.